Drugs / Cx401
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00475410 | Feb 2007 → Aug 2009 | anal fistula | Tigenix S.A.U. | Completed | Missed primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cx401 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00475410 ↗ |